Dov Kadmon, M.D.
Picture
Positions
- Professor
-
Urology
Baylor College of Medicine
Houston, TX US
- Member
-
Dan L Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, Texas United States
Addresses
- Baylor College of Medicine Medical Center (Clinic)
-
7200 Cambridge, Suite 10B
Houston, TX 77030
United States
Phone: (713) 798-4001
Education
- MD from Hadassah Medical School
- 01/1970 - Jerusalem, Israel
- Internship at Jaffa Government Hospital
- 01/1972 - Tel Aviv, Israel
- Residency at Rokah Municipal Governmental Medical Center
- 01/1976 - Jerusalem, Israel
- General Surgery
- Residency at Washington University School of Medicine
- 01/1980 - St. Louis, Missouri United States
- Urology
- Fellowship at Washington University Affiliate Hospitals
- 01/1982 - St. Louis, Missouri United States
- Urologic Oncology (Basic Research, Sponsored by the AUA)
Certifications
- American Board of Urology
Professional Interests
- Prostate Cancer and Urologic Oncology
Professional Statement
Dov Kadmon, M.D., is a Board-certified urologist and Professor of Urology at BCM. His practice is focused on the diagnosis and treatment of prostate cancer. He is an experienced surgeon, who has performed over 1,000 open radical prostatectomies and over 1,000 robotic-assisted (da Vinci) laparoscopic radical prostatectomies. He offers his patients state-of-the-art surgical techniques as well as an operation tailored to each individual’s special needs.Dr. Kadmon has an extensive record of prostate cancer research, both basic science and clinical. He is recognized nationally and internationally for his contributions to the field and has published over 150 papers in the medical literature. He was awarded numerous grants by the National Cancer Institute to support his research and has served as a consultant to the NCI on the topic of prostate cancer.
Websites
VIICTR Research Database
Selected Publications
- Ayala G, Yan J, Li R, Ding Y, Thompson TC, Mims MP, Hayes TG, MacDonnell V, Lynch RG, Frolov A, Miles BJ, Wheeler TM, Harper JW, Tsai MJ, Ittmann MM, Kadmon D "Bortezomib-mediated inhibition of steroid receptor coactivator-3 degradation leads to activated Akt.." Clin. Cancer Res.. 2008 Nov 15;14(22):7511-8. Pubmed PMID: 19010869
- Ayala GE, Dai H, Powell M, Li R, Ding Y, Wheeler TM, Shine D, Kadmon D, Thompson T, Miles BJ, Ittmann MM, Rowley D "Cancer-related axonogenesis and neurogenesis in prostate cancer.." Clin. Cancer Res.. 2008 Dec 1;14(23):7593-603. Pubmed PMID: 19047084
- Ayala GE, Muezzinoglu B, Hammerich KH, Frolov A, Liu H, Scardino PT, Li R, Sayeeduddin M, Ittmann MM, Kadmon D, Miles BJ, Wheeler TM, Rowley DR "Determining Prostate Cancer-Specific Death through Quantification of Stromogenic Carcinoma Area in Prostatectomy Specimens.." Am. J. Pathol.. 2011 Jan;178(1):79-87. Pubmed PMID: 21224046
- Sonpavde G, Thompson TC, Jain RK, Ayala GE, Kurosaka S, Edamura K, Tabata K, Ren C, Goltsov AA, Mims MP, Hayes TG, Ittmann MM, Wheeler TM, Gee A, Miles BJ, Kadmon D "GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy.." Clin. Cancer Res.. 2011 Nov 15;17(22):7174-82. Pubmed PMID: 21933889
- Wang H, Yang G, Timme TL, Fujita T, Naruishi K, Frolov A, Brenner MK, Kadmon D, Thompson TC "IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.." Cancer Gene Ther.. 2007 Oct;14(10):819-27. Pubmed PMID: 17627292
- Sonpavde G, Chi KN, Powles T, Sweeney CJ, Hahn N, Hutson TE, Galsky MD, Berry WR, Kadmon D "Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.." Cancer. 2007 Dec 15;110(12):2628-39. Pubmed PMID: 17941029
- Yanagisawa N, Li R, Rowley D, Liu H, Kadmon D, Miles BJ, Wheeler TM, Ayala GE "Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy.." Hum. Pathol.. 2008 Feb;39(2):282-91. Pubmed PMID: 18206496
- Thompson TC, Tahir SA, Li L, Watanabe M, Naruishi K, Yang G, Kadmon D, Logothetis CJ, Troncoso P, Ren C, Goltsov A, Park S "The role of caveolin-1 in prostate cancer: clinical implications.." Prostate Cancer Prostatic Dis.. 2010 Mar;13(1):41436. Pubmed PMID: 19581923
- Tabata K, Watanabe M, Naruishi K, Edamura K, Satoh T, Yang G, Abdel Fattah E, Wang J, Goltsov A, Floryk D, Soni SD, Kadmon D, Thompson TC "Therapeutic effects of gelatin matrix-embedded IL-12 gene-modified macrophages in a mouse model of residual prostate cancer.." Prostate Cancer Prostatic Dis.. 2009;12(3):301-9. Pubmed PMID: 19104507
- Tahir SA, Yang G, Goltsov AA, Watanabe M, Tabata K, Addai J, Fattah el MA, Kadmon D, Thompson TC "Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer.." Cancer Res.. 2008 Feb 1;68(3):731-9. Pubmed PMID: 18245473
Memberships
- Southwest Oncology Group
- Member
- American Medical Association
- Member
- St. Louis Urological Society
- Member
- American Urological Association
- Member
- American Association for the Advancement of Science
- Member
- The Society of University Urologists
- Member
- Society for Basic Urologic Research
- Member
Skills
- Research Interests
- Gene therapy and immunotherapy (vaccines) for prostate cancer; biological therapy in prostate cancer; prevention of prostate cancer
- Clinical Interests
- Prostate cancer and urologic oncology with special interest in prostate cancer surgery
Log In to edit your profile
